Loading…
Capabilities & focus
Process-development services
Formulation developmentClinical and commercial GMP manufacturing
Molecule types
Small moleculePeptide
Technology platforms
CESS (Controlled Expansion of Supercritical Solutions) nanoformingstated as capable of producing pure API particles down to 10 nm; STARMAPan AI platform for candidate molecule selection; plus formulation services for small molecules and biologics (proteinspeptides)analytical chemistry and IP-protection consultancy. The company states recipe control via automationand clean-in-place (CIP) and wash-in-place (WIP) capability.
Public
Ownership
2015
Founded
Live record · illustrative seed data · scores deterministic, rules-based — not AI. Not a regulatory determination or endorsement.